152 related articles for article (PubMed ID: 17240625)
1. [Megakaryopoietic cytokine levels in patients with essential thrombocythemia and their relationship with clinical and biochemical features].
Marta RF; Goette NP; Molinas FC
Medicina (B Aires); 2006; 66(6):540-6. PubMed ID: 17240625
[TBL] [Abstract][Full Text] [Related]
2. [Anagrelide-induced changes of megakaryopoiesis during therapy of chronic myeloproliferative disorders with thrombocythemia].
Thiele J; Kvasnicka HM; Schmitt-Gräff A
Pathologe; 2002 Nov; 23(6):426-32. PubMed ID: 12436295
[TBL] [Abstract][Full Text] [Related]
3. TPO, but not soluble-IL-6 receptor, levels increase after anagrelide treatment of thrombocythemia in chronic myeloproliferative disorders.
Palmblad J; Björkholm M; Kutti J; Lärfars G; Löfvenberg E; Markevärn B; Merup M; Mauritzson N; Westin J; Samuelsson J; Birgegård G
Int J Med Sci; 2008 Apr; 5(2):87-91. PubMed ID: 18414650
[TBL] [Abstract][Full Text] [Related]
4. Circulating levels of thrombopoietic and inflammatory cytokines in patients with clonal and reactive thrombocytosis.
Hsu HC; Tsai WH; Jiang ML; Ho CH; Hsu ML; Ho CK; Wang SY
J Lab Clin Med; 1999 Oct; 134(4):392-7. PubMed ID: 10521086
[TBL] [Abstract][Full Text] [Related]
5. Anagrelide platelet-lowering effect is due to inhibition of both megakaryocyte maturation and proplatelet formation: insight into potential mechanisms.
Espasandin YR; Glembotsky AC; Grodzielski M; Lev PR; Goette NP; Molinas FC; Marta RF; Heller PG
J Thromb Haemost; 2015 Apr; 13(4):631-42. PubMed ID: 25604267
[TBL] [Abstract][Full Text] [Related]
6. Thrombopoietin serum concentration in patients with reactive and myeloproliferative thrombocytosis.
Uppenkamp M; Makarova E; Petrasch S; Brittinger G
Ann Hematol; 1998 Nov; 77(5):217-23. PubMed ID: 9858147
[TBL] [Abstract][Full Text] [Related]
7. Endogenous megakaryocytic colony formation and thrombopoietin sensitivity of megakaryocytic progenitor cells are useful to distinguish between essential thrombocythemia and reactive thrombocytosis.
Mi JQ; Blanc-Jouvan F; Wang J; Sotto MF; Cousin F; Castinel A; Chauvet M; Sotto JJ; Polack B; Mossuz P
J Hematother Stem Cell Res; 2001 Jun; 10(3):405-9. PubMed ID: 11454315
[TBL] [Abstract][Full Text] [Related]
8. Effects of recombinant human thrombopoietin alone and in combination with erythropoietin and early-acting cytokines on human mobilized purified CD34+ progenitor cells cultured in serum-depleted medium.
Birkmann J; Oez S; Smetak M; Kaiser G; Kappauf H; Gallmeier WM
Stem Cells; 1997; 15(1):18-32. PubMed ID: 9007219
[TBL] [Abstract][Full Text] [Related]
9. Spontaneous proliferative megakaryocytopoiesis and platelet hyperreactivity in essential thrombocythemia: is thrombopoietin the link?
Bellucci S; Michiels JJ
Ann Hematol; 2000 Feb; 79(2):51-8. PubMed ID: 10741915
[TBL] [Abstract][Full Text] [Related]
10. Thrombopoietin levels in patients with primary and reactive thrombocytosis.
Cerutti A; Custodi P; Duranti M; Noris P; Balduini CL
Br J Haematol; 1997 Nov; 99(2):281-4. PubMed ID: 9375739
[TBL] [Abstract][Full Text] [Related]
11. The clinical spectrum of thrombocytosis and thrombocythemia.
Frenkel EP
Am J Med Sci; 1991 Jan; 301(1):69-80. PubMed ID: 1994734
[TBL] [Abstract][Full Text] [Related]
12. Treatment of essential thrombocythemia with anagrelide.
Chintagumpala MM; Kennedy LL; Steuber CP
J Pediatr; 1995 Sep; 127(3):495-8. PubMed ID: 7658287
[TBL] [Abstract][Full Text] [Related]
13. Thrombopoietic cytokines and platelet count in multiple myeloma.
Ozkurt ZN; Yağci M; Sucak GT; Kirazli S; Haznedar R
Platelets; 2010; 21(1):33-6. PubMed ID: 19891528
[TBL] [Abstract][Full Text] [Related]
14. Cytokine-induced expansion of human CD34+ stem/progenitor and CD34+CD41+ early megakaryocytic marrow cells cultured on normal osteoblasts.
Ahmed N; Khokher MA; Hassan HT
Stem Cells; 1999; 17(2):92-9. PubMed ID: 10195569
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-6 and interleukin-11 act synergistically with thrombopoietin and stem cell factor to modulate ex vivo expansion of human CD41+ and CD61+ megakaryocytic cells.
Lazzari L; Henschler R; Lecchi L; Rebulla P; Mertelsmann R; Sirchia G
Haematologica; 2000 Jan; 85(1):25-30. PubMed ID: 10629587
[TBL] [Abstract][Full Text] [Related]
16. Expansion of megakaryocyte precursors and stem cells from umbilical cord blood CD34+ cells in collagen and liquid culture media.
Shaw PH; Olszewski M; Kletzel M
J Hematother Stem Cell Res; 2001 Jun; 10(3):391-403. PubMed ID: 11454314
[TBL] [Abstract][Full Text] [Related]
17. Hypersensitivity of circulating progenitor cells to megakaryocyte growth and development factor (PEG-rHu MGDF) in essential thrombocythemia.
Axelrad AA; Eskinazi D; Correa PN; Amato D
Blood; 2000 Nov; 96(10):3310-21. PubMed ID: 11071622
[TBL] [Abstract][Full Text] [Related]
18. Serial serum thrombopoietin levels in a pregnant woman with essential thrombocythaemia.
Kanda Y; Chiba S; Tanaka Y; Miwa A; Togawa A; Kato T; Miyazaki H; Nishino R; Yazaki Y; Hirai H
Br J Haematol; 1999 Apr; 105(1):271-3. PubMed ID: 10233392
[TBL] [Abstract][Full Text] [Related]
19. Effects of anagrelide on megakaryopoiesis and platelet production.
Thiele J; Kvasnicka HM; Schmitt-Graeff A
Semin Thromb Hemost; 2006 Jun; 32(4 Pt 2):352-61. PubMed ID: 16810611
[TBL] [Abstract][Full Text] [Related]
20. Dysregulation of stromal derived factor 1/CXCR4 axis in the megakaryocytic lineage in essential thrombocythemia.
Salim JP; Goette NP; Lev PR; Chazarreta CD; Heller PG; Alvarez C; Molinas FC; Marta RF
Br J Haematol; 2009 Jan; 144(1):69-77. PubMed ID: 19006565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
